{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:17:48Z","timestamp":1786119468068,"version":"build-2736575974"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,11,27]]},"DOI":"10.1097\/qad.0b013e328340a21f","type":"journal-article","created":{"date-parts":[[2010,11,8]],"date-time":"2010-11-08T22:23:22Z","timestamp":1289255002000},"page":"2797-2801","source":"Crossref","is-referenced-by-count":15,"title":["Impact of atazanavir-based HAART regimen on the carotid intima\u2013media thickness of HIV-infected persons: a comparative prospective cohort"],"prefix":"10.1097","volume":"24","author":[{"given":"Luc","family":"de Saint-Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Bressollette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Perfezou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Bellein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Ansart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Vallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Pasquier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210130","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1097\/QAD.0b013e32832d3b85","article-title":"Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study","volume":"23","author":"Grunfeld","year":"2009","journal-title":"AIDS"},{"key":"R2-5-20210130","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/QAD.0b013e328333ea9e","article-title":"Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men","volume":"24","author":"Lo","year":"2010","journal-title":"AIDS"},{"key":"R3-5-20210130","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/QAD.0b013e328306a6c5","article-title":"Subclinical coronary atherosclerosis, HIV infection and antiretroviral therapy: Multicenter AIDS Cohort Study","volume":"22","author":"Kingsley","year":"2008","journal-title":"AIDS"},{"key":"R4-5-20210130","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1089\/apc.2009.0102","article-title":"Cardiovascular risk assessment in antiretroviral-na\u00efve HIV patients","volume":"23","author":"Maggi","year":"2009","journal-title":"AIDS Patient Care STDS"},{"key":"R5-5-20210130","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1086\/605578","article-title":"Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy","volume":"49","author":"Ross","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R6-5-20210130","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.atherosclerosis.2008.10.012","article-title":"Human immunodeficiency virus per se exerts atherogenic effects","volume":"204","author":"Oliviero","year":"2009","journal-title":"Atherosclerosis"},{"key":"R7-5-20210130","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.atherosclerosis.2006.12.022","article-title":"Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis","volume":"196","author":"Lorenz","year":"2007","journal-title":"Atherosclerosis"},{"key":"R8-5-20210130","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1161\/01.CIR.0000124480.32233.8A","article-title":"Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection","volume":"109","author":"Hsue","year":"2004","journal-title":"Circulation"},{"key":"R9-5-20210130","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1161\/STROKEAHA.106.479030","article-title":"The role of immunity and inflammation in the progression of atherosclerosis in patients with HIV infection","volume":"38","author":"Coll","year":"2007","journal-title":"Stroke"},{"key":"R10-5-20210130","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/QAD.0b013e32832b514b","article-title":"Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis","volume":"23","author":"Hsue","year":"2009","journal-title":"AIDS"},{"key":"R11-5-20210130","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1097\/QAD.0b013e32832d7aa8","article-title":"Association of hepatitis C virus and HIV infection with subclinical atherosclerosis in the women's interagency HIV study","volume":"23","author":"Tien","year":"2009","journal-title":"AIDS"},{"key":"R12-5-20210130","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1468-1293.2005.00324.x","article-title":"Carotid intima-media thickness is slightly increased over time in HIV-1-infected patients","volume":"6","author":"Merci\u00e9","year":"2005","journal-title":"HIV Med"},{"key":"R13-5-20210130","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/jac\/dkm414","article-title":"Predictive factors of vascular intima media thickness in HIV-positive subjects","volume":"61","author":"Bongiovanni","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"R14-5-20210130","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1468-1293.2009.00766.x","article-title":"Nonconcordance between subclinical atherosclerosis and the calculated Framingham risk score in HIV-infected patients: relationships with serum markers of oxidation and inflammation","volume":"11","author":"Parra","year":"2010","journal-title":"HIV Med"},{"key":"R15-5-20210130","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.atherosclerosis.2008.05.028","article-title":"Increased carotid intima-media thickness in HIV patients treated with protease inhibitors as compared to nonnucleoside reverse transcriptase inhibitors","volume":"202","author":"Sankatsing","year":"2009","journal-title":"Atherosclerosis"},{"key":"R16-5-20210130","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/01.aids.0000171406.53737.f9","article-title":"Carotid artery intima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure","volume":"19","author":"Currier","year":"2005","journal-title":"AIDS"},{"key":"R17-5-20210130","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1086\/516616","article-title":"Metabolic syndrome and subclinical atherosclerosis in patients infected with HIV","volume":"44","author":"Mangili","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R18-5-20210130","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.lpm.2007.09.022","article-title":"Metabolic syndrome: a major risk factor for atherosclerosis in HIV-infected patients (SHIVA study)","volume":"37","author":"De Saint Martin","year":"2008","journal-title":"Presse Med"},{"key":"R19-5-20210130","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.atherosclerosis.2009.06.011","article-title":"Lipodystrophy and antiretroviral therapy as predictors of sub-clinical atherosclerosis in human immunodeficiency virus infected subjects","volume":"208","author":"Guaraldi","year":"2010","journal-title":"Atherosclerosis"},{"key":"R20-5-20210130","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1086\/597475","article-title":"Increase in carotid artery intima-media thickness and arterial stiffness but improvement in several markers of endothelial function after initiation of antiretroviral therapy","volume":"199","author":"Van Vonderen","year":"2009","journal-title":"J Infect Dis"},{"key":"R21-5-20210130","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3851\/IMP1491","article-title":"Endothelial function is impaired in HIV-infected patients with lipodystrophy","volume":"15","author":"Masi\u00e1","year":"2010","journal-title":"Antivir Ther"},{"key":"R22-5-20210130","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2174\/157016207780636498","article-title":"Correlations between carotid IMT, factor VIII activity level and metabolic disturbances: a cardio-vascular risk factor in the HIV positive persons","volume":"5","author":"De Saint Martin","year":"2007","journal-title":"Curr HIV Res"},{"key":"R23-5-20210130","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1136\/hrt.2009.177774","article-title":"HIV positivity, protease inhibitor exposure and subclinical atherosclerosis: a systematic review and meta-analysis of observational studies","volume":"95","author":"Hulten","year":"2009","journal-title":"Heart"},{"key":"R24-5-20210130","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/QAD.0b013e32811ebf79","article-title":"Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults","volume":"21","author":"Currier","year":"2007","journal-title":"AIDS"},{"key":"R25-5-20210130","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.atherosclerosis.2008.08.017","article-title":"Cardiovascular prevention in HIV patients: results from a successful intervention program","volume":"204","author":"Lima","year":"2009","journal-title":"Atherosclerosis"},{"key":"R26-5-20210130","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/01.aids.0000171405.46113.bf","article-title":"Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine","volume":"19","author":"Fisac","year":"2005","journal-title":"AIDS"},{"key":"R27-5-20210130","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/jac\/dkp250","article-title":"A pilot randomized trial comparing an intensive versus a standard intervention in stable HIV-infected patients with moderate-high cardiovascular risk","volume":"64","author":"Masi\u00e1","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"R28-5-20210130","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2147\/VHRM.S5206","article-title":"Prevention of atherosclerosis in patients living with HIV","volume":"5","author":"de Lorenzo","year":"2009","journal-title":"Vasc Health Risk Manag"},{"key":"R29-5-20210130","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1185\/030079905X65439","article-title":"Comparison of atazanavir with lopinavir\/ritonavir in patients with prior protease inhibitor failure: a randomized multinational trial","volume":"21","author":"Cohen","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"R30-5-20210130","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1097\/00002030-200411050-00005","article-title":"The effects of HIV protease inhibitors atazanavir and lopinavir\/ritonavir on insulin sensitivity in HIV-seronegative healthy adults","volume":"18","author":"Noor","year":"2004","journal-title":"AIDS"},{"key":"R31-5-20210130","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"key":"R33-5-20210130","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1161\/01.CIR.91.10.2528","article-title":"Effect of lipid lowering by pravastatin on progression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS)","volume":"91","author":"Jukema","year":"1995","journal-title":"Circulation"},{"key":"R34-5-20210130","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.atherosclerosis.2005.06.049","article-title":"Premature atherosclerosis in HIV positive patients and cumulated time of exposure to antiretroviral therapy (SHIVA study)","volume":"185","author":"De Saint Martin","year":"2006","journal-title":"Atherosclerosis"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/QAD.0b013e328340a21f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:36:27Z","timestamp":1786041387000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-201011270-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,27]]},"references-count":33,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e328340a21f","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11,27]]}}}